Stay safe and stay healthy

Please note our office new address is 3702 Pender Drive, Suite 170. Fairfax, VA 22030 

 

https://us.pomelo.health/ozlemgokeralpan/guest/#/wz/book

Lysosomal Treatment Center

Treatment Personalized to Your Needs for Great Results

Ozlem Goker-Alpan MD, LLC
Treatment Info

Treatment Info

LTC offers leading treatments at any of our three clinics in Virginia or Maryland...
More Info
Referring Doctors

Referring Doctors

Referral of patients is easy through our online form... 
Learn More
LYSOSOMAL DISORDERS

LYSOSOMAL DISORDERS

Learn about the signs and implications of lysosomal disorders and current treatments.
More Info

Dr. Goker Speaks at WorldSymposium

Dr. Ozlem Goker-Alpan will be speaking at the CME Satellite Symposium: Critical Impact of Inflammation in Lysosomal Diseases: Unlocking future treatments and improving outcomes at the WORLDSymposium 2021 this Thursday, February 11, 2021, 12:00 - 1:00 PM

Monitoring and management of inflammation in Gaucher disease: Challenges, options and useful tools.(Accredited provider: Postgraduate Institute for Medicine (PIM); Jointly provided by PIM and Saterdalen & Associates, LLC; Supported by an independent educational grant from Takeda)

https://sponsor.worldsymposia.org/wp-content/uploads/Takeda-Handout-v1.pdf
Image

A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Children With Gaucher Disease Under 5 Years Old

Study Description

Brief Summary:

The main aim of this study is to learn if velaglucerase alfa (VPRIV) improves growth and symptoms in participants with Gaucher disease that are under 5 years old. Symptoms will be checked with blood tests.

Another aim of the study is to check if there are any side effects from VPRIV.

The study will take place in the United States.

After the study doctor has checked that each child can take part in this study, part of each participant's medical record will be recorded. Then, information from each participant's ongoing treatment with VPRIV, which will follow standard patient care, will be recorded. In this study, standard patient care means that the participants will receive VPRIV as they usually would from their doctor. Also, no extra tests will be carried out.

ltcteamshot.png

Welcome to
Lysosomal
Treatment Center

Our commitment is to provide high quality care for individuals with lysosomal storage diseases and other rare disorders by utilizing a variety of tested treatments and protocols, conduct local programs to increase awareness and to offer compassionate care and platform for the patients affected by these debilitating disorders.
cta-logo

Request an Appointment, Call 703-261-6220

Schedule Your Appointment Today

Connect with us

3702 Pender Drive, Suite 170,
Fairfax VA 22030

  • dummy+1 703-261-6220

  • dummy+1 703 991-6592

  • dummy info@LDRTC.org

Search